Cargando…
Response to Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Response to Letter]
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588288/ https://www.ncbi.nlm.nih.gov/pubmed/36284895 http://dx.doi.org/10.2147/VHRM.S392327 |
| _version_ | 1784814097285513216 |
|---|---|
| author | Abukhalil, Abdallah Damin |
| author_facet | Abukhalil, Abdallah Damin |
| author_sort | Abukhalil, Abdallah Damin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9588288 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95882882022-10-24 Response to Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Response to Letter] Abukhalil, Abdallah Damin Vasc Health Risk Manag Response to Letter Dove 2022-10-19 /pmc/articles/PMC9588288/ /pubmed/36284895 http://dx.doi.org/10.2147/VHRM.S392327 Text en © 2022 Abukhalil. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Response to Letter Abukhalil, Abdallah Damin Response to Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Response to Letter] |
| title | Response to Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Response to Letter] |
| title_full | Response to Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Response to Letter] |
| title_fullStr | Response to Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Response to Letter] |
| title_full_unstemmed | Response to Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Response to Letter] |
| title_short | Response to Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Response to Letter] |
| title_sort | response to commentary and critique to “vte prophylaxis therapy: clinical practice vs clinical guidelines” by abukhalil et al [response to letter] |
| topic | Response to Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588288/ https://www.ncbi.nlm.nih.gov/pubmed/36284895 http://dx.doi.org/10.2147/VHRM.S392327 |
| work_keys_str_mv | AT abukhalilabdallahdamin responsetocommentaryandcritiquetovteprophylaxistherapyclinicalpracticevsclinicalguidelinesbyabukhaliletalresponsetoletter |